Home / 510(k) Clearances / K172714

510(k) K172714

LipiVage by Genesis Biosystems, Inc. — Product Code MUU

K172714 is an FDA 510(k) premarket notification submitted by Genesis Biosystems, Inc. for the device "LipiVage". The FDA issued a decision of Substantially Equivalent on December 8, 2017. The device falls under product code MUU (System, Suction, Lipoplasty), a Class II device regulated under 21 CFR 878.5040. Genesis Biosystems, Inc. has at least 3 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
December 8, 2017
Date Received
September 8, 2017
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
System, Suction, Lipoplasty
Device Class
Class II
Regulation Number
878.5040
Review Panel
SU
Submission Type

See Federal Register Notice at 86 FR 50887 “Consolidation of Devices That Process Autologous Human Cells, Tissues, and Cellular and Tissue-Based Products at the Point of Care to Produce a Therapeutic Article” (FRN) (FDA-2021-N-0881).

Other clearances by Genesis Biosystems, Inc.

  • K131142 — GENESIS LED WANDS (November 27, 2013)
  • K082484 — ACCELAWAVE SYSTEM (September 12, 2008)
  • K081578 — ACCELA SYSTEM (June 20, 2008)

Other clearances for product code MUU

  • K210528 — IntelliFat Disposable Adipose Tissue Harvesting and Transfer Kit, IntelliFat Bod (March 16, 2022)
  • K203800 — SyntrFuge System (July 2, 2021)
  • K202443 — Smart Kit Basic, Smart Kit Pro (March 11, 2021)
  • K193539 — REVOLVE ENVI 600 Advanced Adipose System (May 28, 2020)
  • K193363 — Dermapose Refresh (April 14, 2020)
  • K182732 — JTL-250-01 (November 18, 2019)
  • K191564 — Progenikine Concentrating System 25 mL System (November 7, 2019)
  • K190386 — KTA Adipose Treatment Kit (October 10, 2019)
  • K190278 — AuraGen 123 Suction Lipoplasty System (A123) (May 3, 2019)
  • K172717 — Automatic Tissue Processing Unit (May 25, 2018)

FDA data resources